Highlights
Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with...
Symbol: MBLY ISIN: US60741F1049
Trendbetrachtung auf Basis 6 Monate: Die Aktie des Technologie-Unternehmens aus Jerusalem konnte im vergangenen Halbjahr über 33 Prozent zulegen....
BOSTON, June 05, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
Symbol: MRK ISIN: DE0006599905
Trendbetrachtung auf Basis 6 Monate: Die Aktie des Chemieunternehmens aus Darmstadt verlor im vergangenen Halbjahr rund 6 Prozent...
The development of mRNA vaccines against COVID-19 has showcased the potential of RNA-based approaches, generating significant enthusiasm and investment in the field. RNA-based therapeutics...
Enjoy the spring season with new experiences to make your days brighter! From outdoor activities like nature walks and festivals, to exploring new areas...
